Fundz

Who to call at Accendra Health, Inc., and when

Fundz watches for the moments Accendra Health, Inc. starts buying, and tells you who to reach.

  • An alert the day Accendra Health, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Accendra Health, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Accendra Health, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2
Back to SEC Filings
Executive ChangeItem 5.02 · 8-KMEDIUM RiskNeutral

Accendra Health, Inc.

A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.

accendrahealth.com
Filed: Nov 3, 2026Glen Allen, VirginiaCIK: 0000075252Health Care
Full company profileView on SEC.gov

Leadership shakeup: 3 executive changes at Accendra Health in the last 90 days. Clusters like this usually mean more senior seats open over the next few months.

The seat is still open. No replacement has been named 19 days after this filing.

See every company with multiple executive changes →

Executive Summary

Analysis of 8-K filing content

Perry A. Bernocchi, Accendra Health's Executive Vice President and Chief Operating Officer, transitioned to Strategic Advisor to the CEO effective October 29, 2026, through December 31, 2026. He retains his base salary and bonus eligibility, signaling a planned leadership transition during a critical period.

Other companies that filed an 8-K Item 5.02 (Executive Change) the same week

Analyzed filings with the same item number within 7 days, from SEC EDGAR via Fundz.

  • Enovix Corporation (November 3, 2026): Arthi Chakravarthy, Chief Legal Officer and Corporate Secretary of Enovix Corporation, departed from the company effective October 30, 2026.
  • ACM Research, Inc. (November 3, 2026): ACM Research appointed Yue Ma as Chief Operations Officer effective October 1, 2026, bringing semiconductor industry expertise from ASML.
  • Wolverine World Wide, Inc. (November 3, 2026): Susie Kuhn, President of Wolverine's Active Group, departed the company effective September 21, 2026.
  • ATN International, Inc. (November 3, 2026): ATN International extended Mary Mabey's service agreement as Senior Vice President and General Counsel through December 31, 2026, with a Transition Agreement Amendment providing...
  • VISIUM TECHNOLOGIES, INC. (November 3, 2026): Paul R. Taylor, former Chairman and CEO of Visium Technologies, resigned unconditionally on October 26, 2026, effective immediately, citing disagreements with company policies.
  • Concentrix Corporation (November 3, 2026): Concentrix Corporation appointed Chinnu Susan Varghese as Chief Financial Officer effective December 1, 2026, succeeding Andre Valentine who will remain through Q2 2027 to support...

Key Takeaways

Bernocchi stepped down as an executive officer but remains with the company as Strategic Advisor until year-end 2026

He maintains current base salary and 2026 annual bonus eligibility during the transition period

2 more takeaways

Related Filings (1)

1 more filing from Accendra Health, Inc. in the last 90 days

Filing Overview

Form Type8-K
Filing DateNov 3, 2026
Item5.02
CategoryExecutive Change
CIK0000075252
Accession #0001104659-26-122072
Risk LevelMEDIUM
SentimentNeutral
Signalinformational
Topics
leadership transitionexecutive departure

What This Means

A senior executive (CEO, CFO, etc.) has joined, departed, or changed roles. Leadership changes can significantly impact strategy.
View Full Filing on SEC.govBrowse More Filings

Accendra Health, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

4 screens from a live account. No signup.